Orthopedic Splints And Casts Market Analysis & Forecast: 2026-2033
The Orthopedic Splints and Casts market is anticipated to grow at a CAGR of 6.4% with USD 3.68 Bn in 2026 and is expected to reach USD 5.65 Bn in 2033. High prevalence of musculoskeletal diseases such as arthritis and osteoporosis (Osteoporosis affects over 500 million people worldwide), which are associated with growing geriatric population, is expected to drive growth of the orthopedic splints and casts market.
Fiberglass casting material is a modern synthetic material made from fiberglass mesh coated with resin. It is widely used for making medical casts because it is strong but very lightweight compared to traditional plaster. This material helps support broken bones while allowing better comfort and easier movement for patients during recovery.
It is mainly used as a replacement for plaster casts because it is more durable and faster to set. Fiberglass casts reduce weight by about 50%, improve patient comfort, and allow better blood circulation, which can help healing. They also make X-ray monitoring easier because they are more transparent to radiation.
Thermoplastic materials are special plastics that become soft when heated and can be molded easily. They are used to make medical supports as they can be molded to fit the patient and adjusted again if needed during treatment.
These materials save a lot of time and material in treatment. They reduce application time by about 70%, allow unlimited adjustments, as well as lower waste by up to 90%. Patients also prefer them more, with satisfaction scores of 8.5/10 compared to 6.2/10 for traditional casts.
|
Current Event |
Description and its Impact |
|
Rising government focus on trauma care and orthopedic rehabilitation programs |
|
|
Expansion of reimbursement policies for orthopedic devices in developed regions |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Casts segment is projected to account for the largest share of product type in 2026, representing approximately 60% of the total volume. Their widespread application in treating severe fractures, post-surgical immobilization, as well as complex orthopedic conditions is augmenting the market growth. According to the National Institute of Health (NIH), age-related fractures are projected to increase nationally from 2.1 million in 2005 to over 3 million fractures in 2025
Their superior structural integrity as well as ability to provide comprehensive support during the critical healing phases of bone injuries is another growth inducing factor.
According to data from the World Health Organization, fractures represent one of the most common orthopedic injuries globally, with an estimated 178 million new fractures occurring annually worldwide, and the majority of these cases require casting for proper healing and bone alignment.
To learn more about this report, Request Free Sample
Based on end user, hospitals dominate the market, accounting for a significant 55% share in 2026, the comprehensive infrastructure, extensive patient volume, and integrated healthcare delivery systems that position them as the primary treatment centers for orthopedic injuries and conditions requiring splinting and casting interventions. The most common injuries were fractures (27%) and sprains (27%). Injuries were predominantly concentrated in the upper trunk, lower trunk, and wrist. The majority (91%) of injuries occurred in players aged 50 and older, with an 88% surge in injury rates since 2020.
The ability to handle complex trauma cases, emergency situations, as well as multi-disciplinary treatment approaches that usually require immediate application of orthopedic splints and casts is stimulating the growth.
According to the American Hospital Association, hospitals serve as the backbone of emergency medical care, with emergency departments treating millions of patients annually for fractures, sprains, other orthopedic injuries, etc., that mandate immobilization through splints and casts.
To learn more about this report, Request Free Sample
North America account 40% market share in 2026, its sophisticated healthcare infrastructure, extensive network of trauma centers, and established medical device regulatory framework that facilitates rapid adoption of advanced orthopedic splinting and casting solutions. A cross-sectional study of 464 trauma centers across all 50 U.S. states and Washington, D.C. found that states with lower alignment to American College of Surgeons Committee on Trauma (ACS-COT) standards showed a significantly higher expansion of for-profit trauma centers.
The presence of major medical device manufacturers including 3M, DJO Global, Össur, etc., which maintain their headquarters and primary research facilities within the United States and Canada are the factors propelling the market.
The North American healthcare system's emphasis on evidence-based treatment protocols has led to widespread standardization of orthopedic splinting procedures across hospitals, outpatient clinics, and sports medicine facilities.
The Asia Pacific region is poised to be the fastest-growing region through 2026-2033, expanding at a CAGR of approximately 6.2%. Rapid healthcare infrastructure development, increasing healthcare accessibility, as well as escalating awareness of advanced orthopedic care solutions are propelling the regional growth. A study showed that Health service coverage is projected to increase from 53.5% in 2000 to 81.5% by 2030, with Bhutan and Sri Lanka expected to achieve higher levels.
Additionally, initiatives like China's Healthy China 2030 program, which has allocated substantial resources toward upgrading medical facilities and expanding access to quality healthcare services in both urban and rural areas is further stimulating the market.
India's National Health Mission has similarly catalyzed market expansion by establishing new primary healthcare centers as well as upgrading existing facilities with modern medical equipment and supplies. A recent report by the World Health Organization indicate that countries like Vietnam, Thailand, Indonesia, etc., have significantly increased their healthcare spending per capita, with orthopedic care being identified as a priority area due to rising sports-related injuries and an aging population.
The U.S. contributes the highest share in the orthopedic splints and casts market in North America due to its robust healthcare infrastructure, extensive network of specialized orthopedic facilities, as well as high investment in advanced medical technologies.
The emphasis by the U.S. healthcare system on immediate intervention for sports-related injuries and workplace accidents has created substantial demand for orthopedic splints and casts.
In February 2026, Orlando Health has launched a pilot study of a new splint, invented by one of its own physicians, to improve patient care following a hand or wrist injury.
China contributes the highest share in the orthopedic splints and casts market in Asia Pacific owing to its massive healthcare infrastructure development, substantial elderly population, and comprehensive government healthcare reforms.
The rapid urbanization of the country has led to increased workplace as well as traffic accidents, majorly driving the need for fracture management solutions. According to the National Health Commission of China, traffic-related injuries requiring orthopedic intervention have increased substantially over the past decade, with over 200,000 serious traffic accidents annually resulting in bone fractures and requiring splinting or casting procedures.
Some of the major key players in Orthopedic Splints and Casts market include, Essity Aktiebolag - BSN Medical, DJO Global, Inc., Zimmer Biomet Holdings, Inc., Ossur Americas, Inc., Prime Medical, Inc., DeRoyal Industries, Inc., Alimed, Inc., 3M, Orfit Industries N.V., and Corflex, Inc.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.68 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.4% | 2033 Value Projection: | USD 5.65 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Essity Aktiebolag - BSN Medical, DJO Global, Inc., Zimmer Biomet Holdings, Inc., Ossur Americas, Inc., Prime Medical, Inc., DeRoyal Industries, Inc., Alimed, Inc., 3M, Orfit Industries N.V., and Corflex, Inc. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
